Literature DB >> 17337773

Professional antigen-presenting cells of the skin.

Alicia R Mathers1, Adriana T Larregina.   

Abstract

The skin functions as an important pro-inflammatory and immune organ. Accordingly, the epidermis and dermis are highly populated by dendritic cells (DC), which are potent antigen-presenting cells (APC) with important immunostimulatory and migratory activities. Whereas the biological characteristics and immunological functions of epidermal DC known as Langernahs cells (LC) have been the focus of intense research in the past, less is known regarding their dermal counterparts named dermal dendritic cells (DDC). Although it has been widely accepted that LC are the more relevant skin-resident APC, recent experimental evidence challenges this concept and proposes a different role for these important cell populations. In this article we compile recent scientific advances regarding the function of different skin-resident DC and we try to reconcile the new observations with the previously established paradigm.

Entities:  

Mesh:

Year:  2006        PMID: 17337773     DOI: 10.1385/IR:36:1:127

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  47 in total

Review 1.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 2.  Changing paradigms in cutaneous immunology: adapting with dendritic cells.

Authors:  Adriana T Larregina; Louis D Falo
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

Review 3.  Cutaneous dendritic cells.

Authors:  Jenny Valladeau; Sem Saeland
Journal:  Semin Immunol       Date:  2005-08       Impact factor: 11.130

4.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin.

Authors:  R Cerio; C E Griffiths; K D Cooper; B J Nickoloff; J T Headington
Journal:  Br J Dermatol       Date:  1989-10       Impact factor: 9.302

6.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin.

Authors:  A Tang; M Amagai; L G Granger; J R Stanley; M C Udey
Journal:  Nature       Date:  1993-01-07       Impact factor: 49.962

Review 7.  Langerhans cells--revisiting the paradigm using genetically engineered mice.

Authors:  Adrien Kissenpfennig; Bernard Malissen
Journal:  Trends Immunol       Date:  2006-02-03       Impact factor: 16.687

8.  Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.

Authors:  C M Celluzzi; L D Falo
Journal:  J Invest Dermatol       Date:  1997-05       Impact factor: 8.551

9.  Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases.

Authors:  Andreas Wollenberg; Moritz Wagner; Sandra Günther; Andreas Towarowski; Evelyn Tuma; Martina Moderer; Simon Rothenfusser; Stefanie Wetzel; Stefan Endres; Gunther Hartmann
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

10.  Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes.

Authors:  Tracey Baldwin; Sandrine Henri; Joan Curtis; Meredith O'Keeffe; David Vremec; Ken Shortman; Emanuela Handman
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  29 in total

1.  Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.

Authors:  Rebecca J Dearman; Marie Cumberbatch; Gavin Maxwell; David A Basketter; Ian Kimber
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

Review 2.  Developing mRNA-vaccine technologies.

Authors:  Thomas Schlake; Andreas Thess; Mariola Fotin-Mleczek; Karl-Josef Kallen
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

3.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

4.  Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

Authors:  Maelíosa T C McCrudden; Barbara M Torrisi; Sharifah Al-Zahrani; Cian M McCrudden; Marija Zaric; Christopher J Scott; Adrien Kissenpfennig; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Pharmacol       Date:  2014-03-27       Impact factor: 3.765

5.  A Recombinant Rabies Virus Expressing Fms-like Tyrosine Kinase 3 Ligand (Flt3L) Induces Enhanced Immunogenicity in Mice.

Authors:  Yachun Zhang; Jie Yang; Mingming Li; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Virol Sin       Date:  2019-06-28       Impact factor: 4.327

6.  Tobacco smoke-induced immunologic changes may contribute to oral carcinogenesis.

Authors:  Michael Schierl; Daxesh Patel; Wanhong Ding; Amit Kochhar; Katayun Adhami; Xi Kathy Zhou; Andrew J Dannenberg; Richard D Granstein
Journal:  J Investig Med       Date:  2014-02       Impact factor: 2.895

7.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

8.  Quiescent innate response to infective filariae by human Langerhans cells suggests a strategy of immune evasion.

Authors:  Alexis Boyd; Sasisekhar Bennuru; Yuanyuan Wang; Vivornpun Sanprasert; Melissa Law; Damien Chaussabel; Thomas B Nutman; Roshanak Tolouei Semnani
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 9.  Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.

Authors:  Michael R Turner; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-01-11       Impact factor: 3.534

10.  Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.

Authors:  Stephen C Balmert; Cara Donahue Carey; Gabriel D Falo; Shiv K Sethi; Geza Erdos; Emrullah Korkmaz; Louis D Falo
Journal:  J Control Release       Date:  2019-11-19       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.